Literature DB >> 6025479

The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism.

N M Kaplan.   

Abstract

The content of aldosterone, corticosterone, and cortisol has been assayed in normal adrenal tissue obtained at autopsy and in adrenal adenomas from both normotensive and hypertensive patients obtained at autopsy and from patients with primary aldosteronism obtained at surgery. The content of aldosterone and corticosterone in the adenomas of patients with essential hypertension was similar to that of normal adrenal tissue and much less than that of adenomas from patients with primary aldosteronism. Since these results do not appear to reflect various extraneous factors such as assay technique, degradation of steroids, and patient selection, they suggest that most adrenal adenomas found in patients with essential hypertension are not associated with increased aldosterone production. The presence of such adenomas should not, in itself, be considered evidence for primary aldosteronism. The excretion or secretion of aldosterone in 43 hypertensive patients was found to be similar to that of 39 normotensive patients. These results suggest that primary aldosteronism is rarely the cause of "essential" hypertension.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025479      PMCID: PMC297075          DOI: 10.1172/JCI105573

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

Review 1.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

2.  SUPPRESSION OF PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM.

Authors:  J W CONN; E L COHEN; D R ROVNER
Journal:  JAMA       Date:  1964-10-19       Impact factor: 56.272

3.  In vivo and in vitro studies of adrenal secretions in Cushing's syndrome and primary aldosteronism.

Authors:  E G BIGLIERI; S HANE; P E SLATON; P H FORSHAM
Journal:  J Clin Invest       Date:  1963-04       Impact factor: 14.808

4.  Essential hypertension and aldosterone.

Authors:  E H VENNING; I DYRENFURTH; J B DOSSETOR; J C BECK
Journal:  Circulation       Date:  1961-02       Impact factor: 29.690

5.  Study of a large steroid spectrum in normal subjects and hypertensive patients.

Authors:  J GENEST; E KOIW; W NOWACZYNSKI; T SANDOR
Journal:  Acta Endocrinol (Copenh)       Date:  1960-11

6.  A study of the adrenal status in hypertension.

Authors:  A H SHAMMA; J W GODDARD; S C SOMMERS
Journal:  J Chronic Dis       Date:  1958-11

7.  Double isotope derivative assay of aldosterone in biological extracts.

Authors:  B KLIMAN; R E PETERSON
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

8.  Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid.

Authors:  I J MADER; L T ISERI
Journal:  Am J Med       Date:  1955-12       Impact factor: 4.965

9.  Urinary aldosterone and hypertension.

Authors:  M MURAKAMI; R TAKEDA; S MIYABO; S MORIMOTO; K HASUI; M KANEDA; T NAGANO
Journal:  Jpn Heart J       Date:  1962-01

10.  Unusual adrenal cortex.

Authors:  J Nichols
Journal:  J Clin Endocrinol Metab       Date:  1966-05       Impact factor: 5.958

View more
  7 in total

Review 1.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

2.  Screening for adrenal forms of hypertension.

Authors:  L Baer
Journal:  Bull N Y Acad Med       Date:  1976 Jul-Aug

3.  [In vitro corticosteroid biosynthesis in human adrenals. II. Comparison between normal and hyperplastic (Cushing) adrenals (author's transl)].

Authors:  K Sinterhauf; P Herzog; G Diedrichsen; D Lommer
Journal:  Klin Wochenschr       Date:  1974-12-01

Review 4.  Aldosterone and renin in essential hypertension.

Authors:  J Genest; W Nowaczynski; R Boucher; O Kuchel; J M Rojo-Ortega
Journal:  Can Med Assoc J       Date:  1975-09-06       Impact factor: 8.262

5.  The management of patients with primary aldosteronism.

Authors:  P O Granberg; U Adamson; K H Cohn; B Hamberger; P E Lins
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

6.  Activation of aldosterone secretion in primary aldosteronism.

Authors:  R F Spark; S L Dale; P C Kahn; J C Melby
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

Review 7.  Aldosterone and electrolyte balance in human hypertension.

Authors:  J Genest; W Nowaczynski
Journal:  J R Coll Physicians Lond       Date:  1970-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.